OpenBCI is an open-source brain-computer interface](/brain-regions/overview)-computer-interface) (BCI-computer-interface)) platform that provides affordable, accessible EEG) (electroencephalography) hardware and software for research, education, and healthcare applications. Founded in 2013, OpenBCI has democratized neurotechnology by offering low-cost, open-source alternatives to commercial EEG) systems, enabling researchers and developers to conduct neuroscience research and develop BCI-computer-interface) applications without prohibitive expenses[1].
OpenBCI provides a comprehensive range of EEG) hardware platforms designed for different use cases:
The Cyton is an 8-channel biosensing board designed for research applications. It features:
The Cyton serves as the flagship research platform, offering a balance of channel count, signal quality, and accessibility[1:1].
The Ganglion is a compact, portable 4-channel system optimized for:
Despite reduced channel count, the Ganglion maintains 14-bit resolution and offers superior portability for applications requiring movement and field research[1:2].
The Ultracortex is an open-source wearable EEG) headset available in two versions:
The Ultracortex uses spring-loaded dry electrodes that eliminate the need for conductive gel, significantly reducing setup time and enabling rapid data collection[2].
Combining the Cyton with the Daisy module enables 16-channel high-density recording, suitable for:
OpenBCI's software stack provides end-to-end functionality:
The graphical user interface enables:
BrainFlow is a unified library that provides:
LSL enables:
The Python API enables:
EEG)-based have emerged as promising tools for early detection and monitoring of Alzheimer's disease](/diseases/alzheimers-disease) (AD) and mild cognitive impairment (MCI)[4][5]. OpenBCI platforms facilitate research in:
Quantitative EEG) (qEEG) Biomarkers
Event-Related Potentials (ERPs)
Resting-State Networks
OpenBCI's affordability enables larger cohort studies and longitudinal monitoring that would be prohibitively expensive with commercial systems[6].
EEG) research in Parkinson's disease](/diseases/parkinsons-disease) (PD) focuses on:
Motor Cortex-regions/cortex) Activity
Cognitive Impairment Detection
deep brain stimulation-stimulation) Monitoring
OpenBCI platforms enable development of portable monitoring systems for PD patients[7][8].
For patients with locked-in syndrome or complete paralysis:
OpenBCI has been used to develop low-cost AAC (augmentative and alternative communication) devices for ALS patients[9][10].
Multiple studies validate EEG) for neurodegeneration:
| Condition | Sensitivity | Specificity | Key Biomarkers |
|---|---|---|---|
| AD vs. Healthy | 85-90% | 80-85% | Alpha/theta ratio, P300 latency |
| MCI conversion | 75-82% | 78-83% | Resting-state connectivity |
| PD dementia | 88-92% | 82-86% | Beta coherence, P300 amplitude |
Meta-analyses indicate EEG) provides 80-85% accuracy for AD screening, comparable to more expensive neuroimaging[4:1][5:1].
EEG) offers unique advantages for disease progression tracking:
Studies demonstrate EEG) changes precede clinical progression by 6-12 months, enabling predictive modeling[6:1][11].
BCI-computer-interface)-based interventions show promise:
Randomized trials demonstrate cognitive benefits from EEG)-guided neurofeedback in early AD[12].
| Feature | EEG) | fMRI |
|---|---|---|
| Temporal resolution | Milliseconds | Seconds |
| Spatial resolution | 2-3 cm (high-density) | 1-2 mm |
| Cost | $1,000-10,000 | $500,000-2,000,000 |
| Portability | High (portable) | Very low (fixed) |
| Invasive risk | None | None |
| Patient tolerance | High | Moderate |
EEG) provides superior temporal resolution and portability; fMRI offers better spatial resolution. Combined EEG)-fMRI provides complementary information[13].
| Feature | EEG) | fNIRS |
|---|---|---|
| Signal source | Electrical (neurons) | Hemodynamic (blood flow) |
| Temporal resolution | Milliseconds | Seconds |
| Penetration depth | Whole brain | 2-3 cm (cortical) |
| Motion sensitivity | Moderate | Low |
| Cost | $1,000-10,000 | $20,000-80,000 |
fNIRS provides better spatial localization for cortical regions but limited depth. Combined EEG)-fNIRS systems leverage complementary signals[14].
| Feature | EEG) | MEG |
|---|---|---|
| Signal source | Post-synaptic currents | Magnetic fields |
| Spatial resolution | 2-3 cm | 1-2 mm |
| Cost | $1,000-10,000 | $2,000,000-5,000,000 |
| Environmental constraints | Minimal | Shielded room required |
| Clinical availability | Wide | Limited |
MEG offers superior spatial resolution but at dramatically higher cost and with significant environmental constraints.
Advances in ML enable:
Emerging applications include:
Next-generation devices will enable:
| Platform | Channels | Resolution | Sampling Rate | Connectivity |
|---|---|---|---|---|
| Cyton | 8 | 24-bit | 500 Hz | Bluetooth |
| Ganglion | 4 | 14-bit | 250 Hz | Bluetooth/WiFi |
| Ultracortex Mark IV | 8 | 24-bit | 500 Hz | Bluetooth |
| Ultracortex Supernova | 32 | 24-bit | 500 Hz | Bluetooth |
| Cyton+Daisy | 16 | 24-bit | 250 Hz | Bluetooth |
OpenBCI enables several key research directions:
OpenBCI's non-invasive EEG) technology interfaces with several key neurodegenerative disease :
OpenBCI. Open Source EEG) Hardware and Software. Accessed 2024. 2024. ↩︎ ↩︎ ↩︎
McCrimmon CM et al. A portable, wireless, programmable neural recording system for freely behaving rodents. Conference Proceedings IEEE Engineering in Medicine and Biology Society. 2017. ↩︎
BrainFlow Development Team. BrainFlow: Unified API for brain-computer interface. 2024. ↩︎
Dauwan M et al. EEG)-based dynamics of Alzheimer's disease: a systematic review. Neurobiology of Aging. 2021. ↩︎ ↩︎
Cassani R et al. A systematic review of quantitative EEG) for Alzheimer's disease. IEEE Transactions on neural Systems and Rehabilitation Engineering. 2023. ↩︎ ↩︎
Musaeus CS et al. Electroencephalographic connectivity as a biomarker for Alzheimer's disease. brain Communications. 2022. ↩︎ ↩︎
Mo J et al. Electroencephalographic for Parkinson's disease: a systematic review. NeuroImage. 2023. ↩︎
Sharma A et al. EEG)-based machine learning for Parkinson's disease diagnosis and monitoring. npj Parkinson's disease](/diseases/parkinsons-disease). 2023. ↩︎
Wolpaw JR et al. brain-computer interfaces for communication and control. Clinical Neurophysiology. 2002. ↩︎
Kübler A et al. brain-computer communication: the challenge of chronic use. Clinical Neurophysiology. 2009. ↩︎
Babiloni C et al. Italian version of the European Alzheimer's disease consortium (EADC) consensus on EEG) markers for Alzheimer's disease and mild cognitive impairment. Neurological Sciences. 2019. ↩︎
Liew CL et al. Neurofeedback for cognitive enhancement in Alzheimer's disease: a systematic review. Journal of Alzheimer's disease](/diseases/alzheimers-disease). 2022. ↩︎
Huster RJ et al. Methods for simultaneous EEG)-fMRI: an introductory review. Journal of Neuroscience Methods. 2012. ↩︎
Chiarelli AM et al. Merging EEG) and fNIRS: a promising tool for brain monitoring. Annals of Biomedical Engineering. 2016. ↩︎